Table 1.
Characteristics of the studies included in the scoping review (n = 74)
| Variable | No. (%) |
|---|---|
| Year of study | |
| Before 2000 | 1 (1) |
| 2000–2010 | 7 (9) |
| 2011–2020 | 57 (77) |
| After 2020 | 5 (7) |
| Missing | 4 (5) |
| Location | |
| Outside United States | 24 (32) |
| United States | 49 (66) |
| Missing | 1 (1) |
| Geographic settinga | |
| Urban | 42 (57) |
| Suburban | 16 (22) |
| Rural | 24 (32) |
| Missing | 23 (31) |
| Institutional settinga | |
| Medical center or hospital-based inpatient | 30 (41) |
| Community-based | 25 (34) |
| Health clinics | 14 (19) |
| Other | 4 (5) |
| Missing | 4 (5) |
| Location in cancer care continuuma | |
| Prevention | 20 (27) |
| Screening | 39 (53) |
| Treatment | 23 (31) |
| Survivorship | 17 (23) |
| Status of championa | |
| Clinical | 45 (61) |
| Community-based | 16 (22) |
| Other | 15 (20) |
| Leadership | 12 (16) |
| Patient | 3 (4) |
| Engagement of championa | |
| Assigned | 33 (45) |
| Volunteer | 21 (28) |
| Emergent | 13 (18) |
| Other | 15 (20) |
| Missing | 8 (11) |
| Contractor | 1 (1) |
aCategories were not mutually exclusive (some studies included more than one)